...Sino Biological Inc. will provide bioreagents for use in COVID-19 vaccine development under way at GeoVax Labs Inc....

...Associate Editor, Data & Analytics Johnson & Johnson Inovio Pharmaceuticals Inc. Codagenix Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac AG Moderna Inc. GeoVax Labs Inc. Baylor...

...and Steve Usdin, Washington Editor Johnson & Johnson Inovio Pharmaceuticals Inc. Codagenix Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac AG Moderna Inc. GeoVax Labs Inc. Baylor...

...by the time a candidate vaccine would be ready for large-scale deployment, he said. Separately, GeoVax Labs Inc....
...Race is on to Develop Therapies and Vaccines for The Coronavirus Outbreak” ). Steve Usdin, Washington Editor GeoVax Labs Inc. J&J Johnson...

...respond to inquiries. GeoVax Labs Inc. (OTCBB:GOVX), Atlanta, Ga. Leidos Holdings Inc. (NYSE:LDOS), Reston, Va. Business: Cancer Shannon Lehnbeuter GeoVax Labs Inc. Leidos...

...respond to inquiries. GeoVax Labs Inc. (OTCQB:GOVX), Atlanta, Ga. PharmaJet Inc., Golden, Colo. Business: Infectious, Drug delivery Shannon Lehnbeuter GEO-ZM02 GeoVax Labs Inc. PharmaJet...

...viruses. GeoVax Labs Inc. (OTCQB:GOVX), Atlanta, Ga. Product: GEO-EM01 Business: Infectious Indication: Vaccinate against Ebola virus infection Jennie Walters GeoVax Labs Inc. GEO-EM01...

...the three-antibody cocktail ( arevirumab-3 ). Zalgen has arevirumab-3 in preclinical testing for Lassa fever. GeoVax Labs Inc....

...Germany). The business included the ReLASV Antigen Rapid Test to diagnose Lassa fever. GEO-LM01 from GeoVax Labs Inc....
...Seattle, Wash.), is also in preclinical development (see BioCentury Innovations, June 30, 2016) . Elizabeth S. Eaton GEO-LM01 LHF-535 GeoVax Labs Inc. Kineta...

...Solutions for Infectious Diseases (South San Francisco, Calif.) provided AIDSVAX B/E, a gp120 protein vaccine. GeoVax Labs Inc....
...10 months and immunogenicity at 4.5 and 10 months Status: Phase I started Milestone: NA Julian Zhu DNA/MVA GOVX-B11 GeoVax Labs Inc....